REFERENCE
EMEA.EMEA recommends new contraindication for Velcade (bortezomib). Media Release: 20 Mar 2008. Available from: URL: http://www.emea.europa.eu
Rights and permissions
About this article
Cite this article
Velcade [bortezomib] should not be used in patients with acute diffuse infiltrative pulmonary and pericardial disease. React. Wkly. 1196, 4 (2008). https://doi.org/10.2165/00128415-200811960-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200811960-00011